Signature Estate & Investment Advisors’s Entera Bio ENTX Stock Holding History

Signature Estate & Investment Advisors’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$83.8K	Hold	47,328	–	–	﹤0.01%	663
2026 Q1	$52.5K	Hold	47,328	–	–	﹤0.01%	643
2025 Q4	$91.8K	Hold	47,328	–	–	﹤0.01%	600
2025 Q3	$90.9K	Hold	47,328	–	–	﹤0.01%	592
2025 Q2	$89.9K	Hold	47,328	–	–	﹤0.01%	569
2025 Q1	$80.5K	Hold	47,328	–	–	﹤0.01%	543
2024 Q4	$100K	Hold	47,328	–	–	﹤0.01%	530
2024 Q3	$89.9K	Buy	+47,328	New	+$84K	﹤0.01%	517

Other funds holding ENTX

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

PAP

Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return

Signature Estate & Investment Advisors's ENTX Position: Q2 2026 in Review

Signature Estate & Investment Advisors held its Entera Bio (ENTX) position steady in Q2 2026 at 47,328 shares worth $83.8K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Signature Estate & Investment Advisors first reported a position in ENTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $100K in Q4 2024. 3 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

Signature Estate & Investment Advisors held 47,328 shares of Entera Bio worth $83.8K as of Q2 2026.
Signature Estate & Investment Advisors left its Entera Bio share count unchanged in Q2 2026.
Entera Bio made up ﹤0.01% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #663 holding.
Signature Estate & Investment Advisors first reported a position in Entera Bio in Q3 2024 and has held it in 8 quarters since.
Signature Estate & Investment Advisors's Entera Bio position peaked at $100K in Q4 2024.
3 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.